| Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss (NCT00637572) | Endo USA Inc., a Keenova Therapeutics Company | 2004-12-01 |
| The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children (NCT00006064) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss (NCT00000925) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-05-01 |
| Nutrition Intervention in AIDS Wasting (NCT00006167) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1998-01-01 |
| Growth Hormone in the Treatment of HIV-Associated Wasting (NCT00489528) | EMD Serono | 1997-07-01 |
| A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements (NCT00001077) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-06-01 |
| Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting (NCT00004664) | National Center for Research Resources (NCRR) | 1995-06-01 |
| A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome (NCT00000737) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss (NCT00001079) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome (NCT00002127) | Celgene Corporation | |
| A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss (NCT00000854) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome (NCT00002157) | Celgene Corporation | |